These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 8894357
1. The effect of ranitidine on NSAID related dyspeptic symptoms with and without peptic ulcer disease of patients with rheumatoid arthritis and osteoarthritis. Van Groenendael JH, Markusse HM, Dijkmans BA, Breedveld FC. Clin Rheumatol; 1996 Sep; 15(5):450-6. PubMed ID: 8894357 [Abstract] [Full Text] [Related]
2. High-dose ranitidine for the prevention of recurrent peptic ulcer disease in rheumatoid arthritis patients taking NSAIDs. ten Wolde S, Dijkmans BA, Janssen M, Hermans J, Lamers CB. Aliment Pharmacol Ther; 1996 Jun; 10(3):347-51. PubMed ID: 8791962 [Abstract] [Full Text] [Related]
3. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study. Ekström P, Carling L, Wetterhus S, Wingren PE, Anker-Hansen O, Lundegårdh G, Thorhallsson E, Unge P. Scand J Gastroenterol; 1996 Aug; 31(8):753-8. PubMed ID: 8858742 [Abstract] [Full Text] [Related]
4. Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers. Lancaster-Smith MJ, Jaderberg ME, Jackson DA. Gut; 1991 Mar; 32(3):252-5. PubMed ID: 2013419 [Abstract] [Full Text] [Related]
5. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. Ehsanullah RS, Page MC, Tildesley G, Wood JR. BMJ; 1988 Oct 22; 297(6655):1017-21. PubMed ID: 3142593 [Abstract] [Full Text] [Related]
6. Progress in prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee. Hawkey CJ. Am J Med; 1998 Mar 30; 104(3A):67S-74S; discussion 79S-80S. PubMed ID: 9572324 [Abstract] [Full Text] [Related]
7. NSAID-associated upper gastrointestinal damage in patients with rheumatoid arthritis. Dijkmans BA, Janssen M, Vandenbroucke JP, Lamers CB. Scand J Gastroenterol Suppl; 1995 Mar 30; 212():105-8. PubMed ID: 8578222 [Abstract] [Full Text] [Related]
8. Healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions, and relief of dyspeptic symptoms: a commentary on the new data. Talley NJ. Am J Med; 1998 Mar 30; 104(3A):62S-66S; discussion 79S-80S. PubMed ID: 9572323 [No Abstract] [Full Text] [Related]
9. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients. Bianchi Porro G, Lazzaroni M, Petrillo M. Am J Gastroenterol; 1997 Apr 30; 92(4):663-7. PubMed ID: 9128319 [Abstract] [Full Text] [Related]
10. [Ulcer healing with ranitidine and antacids despite continued therapy with non-steroidal anti-rheumatic drugs]. Stock KP, Bach GL. Z Rheumatol; 1988 Apr 30; 47(3):177-81. PubMed ID: 3213266 [Abstract] [Full Text] [Related]
11. Treatment of peptic ulcer induced by non-steroidal anti-inflammatory drugs. Malchow-Møller A. Scand J Gastroenterol Suppl; 1987 Apr 30; 127():87-91. PubMed ID: 3303297 [Abstract] [Full Text] [Related]
12. Use of gastroprotective agents and discontinuations due to dyspepsia with the selective cyclooxygenase-2 inhibitor etoricoxib compared with non-selective NSAIDs. Watson DJ, Bolognese JA, Yu C, Krupa D, Curtis S. Curr Med Res Opin; 2004 Dec 30; 20(12):1899-908. PubMed ID: 15701208 [Abstract] [Full Text] [Related]
13. Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial. Labenz J, Blum AL, Bolten WW, Dragosics B, Rösch W, Stolte M, Koelz HR. Gut; 2002 Sep 30; 51(3):329-35. PubMed ID: 12171952 [Abstract] [Full Text] [Related]
14. New data on healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions. Omeprazole NSAID Steering Committee. Yeomans ND. Am J Med; 1998 Mar 30; 104(3A):56S-61S; discussion 79S-80S. PubMed ID: 9572322 [Abstract] [Full Text] [Related]
15. [Ranitidine in the therapy and prevention of NSAR-induced (non-steroidal anti-rheumatic agents) gastroduodenal lesions in patients with rheumatism]. Simon B, Bergdolt H, Dammann H, Müller P. Z Gastroenterol; 1991 May 30; 29(5):217-21. PubMed ID: 1950028 [Abstract] [Full Text] [Related]
16. Are antacids necessary as routine prescriptives with non-steroidal anti-inflammatory drugs? See Y, Ng SC, Tho KS, Teo SK. Ann Acad Med Singap; 1998 Mar 30; 27(2):219-22. PubMed ID: 9663314 [Abstract] [Full Text] [Related]
17. Peptic ulcer in rheumatoid arthritis--intrinsic or related to drug therapy? Malone DE, McCormick PA, Daly L, Jones B, Long A, Bresnihan B, Molony J, O'Donoghue DP. Br J Rheumatol; 1986 Nov 30; 25(4):342-4. PubMed ID: 3779321 [Abstract] [Full Text] [Related]
18. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis. Rabeneck L, Goldstein JL, Vu A, Mayne TJ, Rublee DA. Am J Gastroenterol; 2005 May 30; 100(5):1043-50. PubMed ID: 15842577 [Abstract] [Full Text] [Related]
19. Double blind, placebo controlled trial on the cytoprotective effect of misoprostol in subjects with rheumatoid arthritis, osteoarthritis and seronegative spondarthropathy on NSAIDs. Chandrasekaran AN, Sambandam PR, Lal HM, Ramakrishnan S, Porkodi R, Krishnamurthy V, Achutan K. J Assoc Physicians India; 1991 Dec 30; 39(12):919-21. PubMed ID: 1816217 [Abstract] [Full Text] [Related]
20. Misoprostol prevents NSAID-induced gastroduodenal lesions in patients with osteoarthritis and rheumatoid arthritis. Saggioro A, Alvisi V, Blasi A, Dobrilla G, Fioravanti A, Marcolongo R. Ital J Gastroenterol; 1991 Dec 30; 23(3):119-23. PubMed ID: 1742504 [Abstract] [Full Text] [Related] Page: [Next] [New Search]